Turalio Alternatives Compared
| Turalio (pexidartinib) | Pexidartinib | Vimseltinib |
|
|---|
| Turalio (pexidartinib) | Pexidartinib | Vimseltinib |
|
|---|---|---|---|
|
Prescription only
Prescribed for Tenosynovial Giant Cell Tumor. Turalio may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Tenosynovial Giant Cell Tumor. Pexidartinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Tenosynovial Giant Cell Tumor. Vimseltinib may also be used for purposes not listed in this medication guide. |
Related suggestions Tenosynovial Giant Cell Tumor
|
| More about Turalio (pexidartinib) | More about Pexidartinib | More about Vimseltinib | |
| Ratings & Reviews | |||
|
Be the first to share your experience with this drug. |
Pexidartinib has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
|
View all Turalio side effects |
View all Pexidartinib side effects |
||
| Drug Class | |||
| Generic Availability | |||
|
N/A |
N/A |
||
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | |||
|
N/A |
N/A |
|
| Brand Names | |||
|
N/A |
Turalio | Romvimza | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
|
26.6 hours |
26.6 hours |
144 hours |
|
| CSA Schedule 1 View glossary of CSA terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. |
|
| Drug Interactions | |||
|
A total of 638 drugs are known to interact with Turalio:
|
A total of 638 drugs are known to interact with Pexidartinib:
|
A total of 136 drugs are known to interact with Vimseltinib:
|
|
| Alcohol/Food/Lifestyle Interactions | |||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||
| Disease Interactions | |||
| First Approval Date | |||
|
August 02, 2019 |
August 02, 2019 |
February 14, 2025 |
|
| WADA Class View classifications | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient Resources | |||
| Professional Resources | |||
| Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.